CLAIM #12203 · Bristol-Myers Squibb Company (BMY) · 2025Q3 earnings call · Oct 30, 2025 · due Jun 30, 2026
“We have a Phase IV switch study that reads out early next year, all will help build physician confidence.”
Adam Lenkowsky · Chief Commercialization Officer
CANNOT_DETERMINE
versus commitment · official band 5 percent
Committed
We have a Phase IV switch study that reads out early next year
Reported
We also reported positive Phase I switch data for cobi
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2025Q3 earnings call.